Kanagawa, Japan

Shiinobu Sasaki

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shiinobu Sasaki. Retrieved from https://idiyas.com/inventor/shiinobu-sasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shiinobu Sasaki

Shiinobu Sasaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of central nervous system diseases.

Latest Patents

Sasaki holds a patent for a heterocyclic compound that exhibits HDAC inhibitory action. This compound is particularly useful for treating neurodegenerative diseases and other related conditions. The patent describes a compound represented by a specific formula, along with its potential medicinal applications.

Career Highlights

Sasaki is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work focuses on innovative solutions that address critical health challenges, particularly in neurology.

Collaborations

Some of his notable coworkers include Masahiro Ito and Takeshi Yamamoto, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Shiinobu Sasaki's work exemplifies the impact of innovative research in the pharmaceutical industry, particularly in developing treatments for complex diseases. His contributions continue to advance the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…